
The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of Pancreas
Author(s) -
Jayabal Pandiaraja,
Venkataraman Subramanian,
Thomas Babu Antomy,
Sathyamoorthy Thirumuruganand,
Dhandapani Subramanian Kumaresan
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/17106.7398
Subject(s) - medicine , pancreas , head of pancreas , carcinoma , gastroenterology , ca19 9 , prospective cohort study , surgery , pancreatic cancer , cancer
Carbohydrate antigen 19-9 (CA 19-9) is a tumour associated antigen. Blood levels may be elevated in benign as well as malignant conditions. Its sensitivity (70-90%) and specificity (68-91%) are inadequate for accurate diagnosis. It can be used to predict the extent of disease and outcome after resection.